Richard B. Moss
Academic Appointments
- Emeritus Faculty-Med Ctr Line, Pediatrics - Pulmonary Medicine
- Member, Child Health Research Institute
Key Documents
Contact Information
-
Clinical Offices
Respiratory Specialties and ENT 730 Welch Rd 1st Floor Palo Alto, CA 94304 Tel Work (650) 724-4788 Fax (650) 497-8791Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-8325Alternate Contact Linda Young Administrative Associate Email Tel Work 650-723-8325Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Allergy/Asthma/Immunology, Pediatric
- Pulmonary Medicine/Cystic Fibrosis, Pediatric
- Allergy and Immunology
Administrative Appointments
- Member, Stanford IRB (2010 - present)
- Executive Committee, SPECTRUM Child Health (2009 - present)
- Director, Allergy-Immunology Fellowship Training Program, Stanford University (2006 - 2011)
- Chief, Allergy-Immunology, Pediatrics, Stanford University (2005 - 2009)
- Director, Cystic Fibrosis Center, Stanford University (1991 - 2009)
- Principal Investigator, CF Therapeutics Development Network Center, Stanford University (1999 - 2009)
Honors and Awards
- Top Doctors as Chosen by Their Peers - Pediatric Pulmology, US News and World Report (2012/2013)
- Top Doctors - Pediatric Pulmonology Ten Years, Castle Connolly Medical Ltd American Registry (2002-2012)
- Professional of the Year, Cystic Fibrosis Foundation, N. Cal chapter (2008)
- Best Doctors in America, Best Doctors (2001-)
- America's Top Pediatricians-Pulmonology, Consumers Research Council of America (2002-)
- Professional of the Year, Cystic Fibrosis Research, Inc. (2003)
Professional Education
| Fellowship: | Stanford University School of Medicine CA (1981) |
| Medical Education: | SUNY Downstate College of Medicine NY (1975) |
| Board Certification: | Diagnostic Laboratory Immunology, American Board of Allergy and Immunology (1986) |
| Board Certification: | Allergy and Immunology, American Board of Allergy and Immunology (1981) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1981) |
| Residency: | Northwestern University IL (1977) |
Graduate & Fellowship Program Affiliations
Community and International Work
- Project/Grant reviewer, International
- Scientific Advisory Board, California
Internet Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
I am interested in the pathogenesis of chronic airways diseases of childhood. My work includes basic and clinical research. In the area of basic research, my laboratory has focused on immunoregulation of inflammation in cystic fibrosis, finding deficiencies of activated T cells from CF patients in production of counter-regulatory cytokines (IL-10, IFN-gamma) and redox metabolism. In the arena of clinical research, as a member of the CFF Therapeutics Development Network our research group conducts many trials. I have particular interests in the areas of aerosol therapy with drugs, biologics and gene vectors; mechanisms of pulmonary inflammation and immunomodulatory therapy; and corrrection of CFTR-dependent cell biology defects. We are also investigating new treatments for CF complications such as diabetes and osteoporosis, internet-based disease management, and trials of asthma drugs.
Clinical Trials
- Recruiting Infant Study of Inhaled Saline in Cystic Fibrosis
- Recruiting Rare Genetic Disorders of the Breathing Airways
- Not Recruiting The EPIC Observational Study
Publications
- Sleep-disordered breathing in children with spinal muscular atrophy Type II and III submitted.
- Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria Clin Exp Allergy. 2013: in press
- Current Treatment Options for Invasive Aspergillosis Drugs of Today. 2013; (3): 213-226
- Current trials in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization Eur Infect Dis. 2013; (in press)
- Pitfalls of drug development: lessons learned from trials of denufosol in cystic fibrosis. J Pediatr. 2013; (4): 676-80
- Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. J Cyst Fibros. 2013; (3): 241-8
Help